Detection of local recurrent prostate cancer after radical prostatectomy in terms of salvage radiotherapy using dynamic contrast enhanced-MRI without endorectal coil

被引:43
|
作者
Rischke, Hans Christian [1 ]
Schaefer, Arnd O. [2 ]
Nestle, Ursula [1 ]
Volegova-Neher, Natalja [1 ]
Henne, Karl [1 ]
Benz, Matthias R. [3 ]
Schultze-Seemann, Wolfgang [4 ]
Langer, Mathias [2 ]
Grosu, Anca L. [1 ]
机构
[1] Univ Freiburg, Dept Radiat Oncol, D-79106 Freiburg, Germany
[2] Univ Freiburg, Dept Diagnost Radiol, D-79106 Freiburg, Germany
[3] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA
[4] Univ Freiburg, Dept Urol, D-79106 Freiburg, Germany
来源
RADIATION ONCOLOGY | 2012年 / 7卷
关键词
Prostate cancer; PSA recurrence; Salvage radiotherapy; Dynamic contrast enhanced MRI; Gross tumor volume; ANTIGEN; ANATOMY; BIOPSY; FOSSA; MEN; PSA; US;
D O I
10.1186/1748-717X-7-185
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To evaluate the value of dynamic contrast enhanced Magnetic Resonance Imaging (DCE-MRI) without endorectal coil (EC) in the detection of local recurrent prostate cancer (PC) after radical prostatectomy (RP). Material and methods: Thirty-three patients with recurrent PC underwent DCE-MRI without EC before salvage radiotherapy (RT). At median 15 (mean 16 +/- 4.9, range 12-27) months after completion of RT all patients showed complete biochemical response. Additional follow up post RT DCE-MRI scans were available. Prostate specific antigen (PSA) levels at the time of imaging were correlated to the imaging findings. Results: In 22/33 patients (67%) early contrast enhancing nodules were detected in the post-prostatectomy fossa on pre-RT DCE-MRI images. The average pre-RT PSA level of the 22 patients with positive pre-RT DCE-MRI findings was significantly higher (mean, 0.74 +/- 0.64 ng/mL) compared to the pre-RT PSA level of the 11 patients with negative pre-RT DCE-MRI (mean, 0.24 +/- 0.13 ng/mL) (p<0.001). All post-RT DCE-MRI images showed complete resolution of initial suspicious lesions. A pre-RT PSA cut-off value of >= 0.54 ng/ml readily predicted a positive DCE-MRI finding. Conclusions: This is the first study that shows that DCE-MRI without EC can detect local recurrent PC with an estimated accuracy of 83% at low PSA levels. All false negative DCE-MRI scans were detected using a PSA cut-off of >= 0.54 ng/mL.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] The Incremental Value of Contrast-Enhanced MRI in the Detection of Biopsy-Proven Local Recurrence of Prostate Cancer After Radical Prostatectomy: Effect of Reader Experience
    Wassberg, Cecilia
    Akin, Oguz
    Vargas, Hebert Alberto
    Shukla-Dave, Amita
    Zhang, Jingbo
    Hricak, Hedvig
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2012, 199 (02) : 360 - 366
  • [42] MRI WITHOUT ENDORECTAL COIL USING DYNAMIC CONTRAST ENHANCED (DCE-) FAT SATURATED T1, HIGH RESOLUTION T2 AND DIFFUSION WEIGHED (DWI) SEQUENCES TO DETECT MACROSCOPIC LOCAL RECURRENCE IN PATIENTS WITH BIOCHEMICAL RECURRENCE AFTER RADICAL PROSTATECTOMY BECAUSE OF PROSTATE CANCER.
    Rischke, H. C.
    Nestle, U.
    Volegova-Neheri, N.
    Henne, K.
    Schaefer, A. O.
    Knippen, S.
    Grosu, A. L.
    RADIOTHERAPY AND ONCOLOGY, 2010, 96 : S388 - S389
  • [43] Local staging of prostate cancer by endorectal MRI using fast spin-echo sequences: Prospective correlation with pathological findings after radical prostatectomy
    Cornud, F
    Belin, X
    Flam, T
    Chretien, Y
    Deslignieres, S
    Paraf, F
    Casanova, JM
    Thiounn, N
    Helenon, O
    Debre, B
    Dufour, B
    Moreau, JF
    BRITISH JOURNAL OF UROLOGY, 1996, 77 (06): : 843 - 850
  • [44] Role of dynamic contrast enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer
    Sciarra, Alessandro
    Panebianco, Valeria
    Salciccia, Stefano
    Gomez, Ana Maria Autran
    Gentilucci, Alessandro
    Gentile, Vincenzo
    JOURNAL OF UROLOGY, 2008, 179 (04): : 642 - 642
  • [45] Health-related quality of life following salvage radical prostatectomy for recurrent prostate cancer after radiotherapy or focal therapy
    Rodler, Severin
    Danninger, Dina
    Eismann, Lennert
    Kazmierczak, Philipp Maximilian
    Jokisch, Friedrich
    Li, Minglun
    Becker, Armin
    Kretschmer, Alexander
    Stief, Christian
    Westhofen, Thilo
    WORLD JOURNAL OF UROLOGY, 2024, 42 (01)
  • [46] Staging prostate cancer with dynamic contrast-enhanced endorectal MR imaging prior to radical prostatectomy:: Experienced versus less experienced readers
    Fütterer, JJ
    Engelbrecht, MR
    Huisman, HJ
    Jager, GJ
    Hulsbergen-van De Kaa, CA
    Witjes, JA
    Barentsz, JO
    RADIOLOGY, 2005, 237 (02) : 541 - 549
  • [47] CORRELATION OF 3-DIMENSIONAL ULTRASOUND COMPUTER-AIDED INTERPRETATION WITH DYNAMIC CONTRAST ENHANCED PELVIC MRI IN THE DETECTION OF POST RADICAL PROSTATECTOMY LOCAL RECURRENCE OF PROSTATE CANCER
    Shimko, Mark
    Knoedler, John
    Mynderse, Lance
    JOURNAL OF UROLOGY, 2010, 183 (04): : E783 - E783
  • [48] Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer
    Sciarra, Alessandro
    Panebianco, Valeria
    Salciccia, Stefano
    Osimani, Marcello
    Lisi, Danilo
    Ciccariello, Mauro
    Passariello, Roberto
    Di Silverio, Franco
    Gentile, Vincenzo
    EUROPEAN UROLOGY, 2008, 54 (03) : 589 - 600
  • [49] PET/CT-Based Salvage Radiotherapy for Recurrent Prostate Cancer After Radical Prostatectomy: Impact on Treatment Management and Future Directions
    le Guevelou, Jennifer
    Achard, Verane
    Mainta, Ismini
    Zaidi, Habib
    Garibotto, Valentina
    Latorzeff, Igor
    Sargos, Paul
    Menard, Cynthia
    Zilli, Thomas
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [50] Defining the characteristics of locally recurrent prostate cancer after radical prostatectomy based on the results of salvage radiotherapy: A multi-center analysis
    Stephenson, AJ
    Shariat, SF
    Zelefsky, DA
    Kattan, MW
    Roehrborn, CG
    Pistenmaa, DA
    Klein, EA
    Kupelian, PA
    Butler, EB
    Leibel, SA
    Scardino, PT
    Slawin, KM
    JOURNAL OF UROLOGY, 2004, 171 (04): : 382 - 382